Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study
Journal of Cardiovascular Development and Disease · 05.09.2024 · 11 (9) · 279
DOI: 10.3390/jcdd11090279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 05.09.2024. Verfasst von Stefan Naydenov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases "Prof. St. Kirkovich", Medical University of Sofia, 1431 Sofia, Bulgaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Resistant hypertension (HTN) is associated with a high risk of cardiovascular complications. Our study aimed to assess the prevalence, characteristics, and treatment of patients with resistant HTN.
Methods
We screened 4340 consecutive cardiovascular patients hospitalized in our clinic and identified 3762 with HTN. Of them, 128 fulfilled criteria for resistant HTN and were included in our study. We matched these patients to 128 hospitalized patients with controlled HTN.
Results
Resistant HTN patients comprised 3.4% of all hypertensive individuals. Most of these patients (67.2%) were at high or very high cardiovascular risk compared to controlled HTN patients (40.6%); p < 0001. Resistant HTN patients more commonly had concomitant chronic kidney disease (CKD) (60.9%), overweight/obesity (52.3%), dyslipidemias (35.2%), smoking (27.3%), and diabetes (21.9%) compared to controlled HTN patients (37.5%, 29.7%, 28.1%, 14.1%, and 7.8%, respectively); p < 0.001. Regression analysis showed the strongest association of resistant HTN with CKD (OR 6.64), stage III HTN (OR 3.07), and obesity/overweight (OR 2.60). In contrast, single-pill combinations (SPCs) were associated with a lower likelihood of uncontrolled HTN (OR 0.58).
Conclusions
Resistant HTN represented a small proportion of all hypertensives in our study, but it was characterized by high/very high cardiovascular risk. Optimized therapy including increased use of SPCs could improve blood pressure control and long-term prognosis for these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Diseases "Prof. St. Kirkovich", Medical University of Sofia, 1431 Sofia, Bulgaria.
ORCID-Profile: Stefan Naydenov, Emil Manov, Nikolay Runev
Zitieren
APA
Naydenov, S., Manov, E., & Runev, N. (2024). Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study. Journal of Cardiovascular Development and Disease, 11(9), 279. https://doi.org/10.3390/jcdd11090279
Vancouver
Naydenov S, Manov E, Runev N. Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study. Journal of Cardiovascular Development and Disease. 2024;11(9):279. doi:10.3390/jcdd11090279
BibTeX
@article{Naydenov2024,
author = {Naydenov, Stefan and Manov, Emil and Runev, Nikolay},
title = {Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study},
journal = {Journal of Cardiovascular Development and Disease},
year = {2024},
volume = {11},
number = {9},
pages = {279},
doi = {10.3390/jcdd11090279}
}
EUVIMED